Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase EARLY_PHASE1 1Phase 2/3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Prostatic Neoplasms 2Glioblastoma 2Stomach Neoplasms 1Pancreatic Neoplasms 1Oligodendroglioma 1Neoplasms 1Mycosis Fungoides 1Melanoma 1Lymphoma, Large B-Cell, Diffuse 1Head and Neck Carcinoma of Unknown Primary 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Gastrointestinal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Ependymoma 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

Radiotherapy 2Biopsy 2poly ICLC 1fluorodopa F 18 1Temozolomide 1Surgical Procedures, Operative 1Standard of Care 1Radiation 1Protein Subunit Vaccines 1Practice Guidelines as Topic 1Perfusion Magnetic Resonance Imaging 1Magnetic Resonance Spectroscopy 1Ketoconazole 1Gadolinium DTPA 1Dynamic Contrast Enhanced Magnetic Resonance Imaging 1Diffusion Magnetic Resonance Imaging 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Oligodendroglioma × Radiation × Clear all
NCT01165632 2025-09-02

Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma

Mayo Clinic

Phase EARLY_PHASE1 Completed
24 enrolled
CNSSarcoma

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡